German Chancellor Olaf Scholz emphasizes significance for Germany as research location at cornerstone laying ceremony Research center to accelerate biopharmaceutical product development Part of Merck’s € 1.5 billion investment program in Darmstadt by 2025 DARMSTADT, GERMANY — Merck, a leading science and technology company, is investing more than € 300 million in a new research […]
Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025 Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 conference call SOUTH SAN FRANCISCO, Calif. — Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it has initiated a restructuring plan to improve operational efficiency […]
New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform Substantially lowers hands-on time, allowing for increased lab productivity WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is […]
Launch of QIAseq xHYB Mycobacterium tuberculosis Panel for research use, enabling culture-free whole genome sequencing from complex samples Panel significantly accelerates TB outbreak tracking and supports detection and management of antimicrobial resistance, critical needs in TB surveillance and control Building upon success of leading diagnostics test QuantiFERON-TB Gold Plus as QIAGEN extends portfolio for TB […]
SINGAPORE — GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into GenScript’s state-of-the-art gene and protein production facility, particularly highlighting the company’s advancements in AI-driven gene […]
Vienna, Austria – Lexogen, a leading company in transcriptomics and Next-Generation Sequencing (NGS) announces the release of RiboCop rRNA Depletion for Plants, a solution that efficiently removes unwanted ribosomal RNA (rRNA) from various plant samples, including roots, seeds, and leaves from different plant species. RiboCop for Plants integrates seamlessly into end-to-end RNA-Seq workflows, enabling researchers to understand plant […]
Program will support faster insights for large-scale studies and drug development SEATTLE – Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has launched its Laboratory Automation Provider Program, enabling automation providers to readily support the adoption of Parse’s Evercode™ single cell products. By combining powerful automation with the […]
Stockholm, Sweden – Renowned genomics pioneer, Bob Kain, has joined Single Technologies as an advisor to support the commercialization of their 3-D DNA sequencing system. Kain is perhaps most famous for his work at Illumina from 1999 to 2014. During this time, he not only helped the company grow from a 30-employee start-up into a […]
Devyser Diagnostics AB announces today it has entered into a co-marketing agreement with Hamilton Bonaduz AG, a leading global manufacturer of laboratory automation technology. The partnership enables Devyser to collaboratively market Hamilton liquid handling technologies, and to facilitate the automation of library preparation of Devyser NGS kits. This enables labs to benefit from a combined […]
OpenCRISPR-1 is publicly available and free to license for ethical research and commercial use BERKELEY, Calif.–Profluent, the AI-first protein design company, today debuted the OpenCRISPRTM initiative, releasing the world’s first open-source, AI-generated gene editor. With this launch, Profluent demonstrates the first successful precision editing of the human genome with customizable gene editors designed from scratch […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
